Join the Kesimpta group to help and get support from people like you.
Kesimpta News
Pharma Payments Might Influence MS Drug Prescriptions, Researchers Argue
THURSDAY, Sept. 18, 2025 — Nearly 4 out of 5 American neurologists prescribing multiple sclerosis (MS) drugs have received at least one payment from the pharmaceutical industry, a new study reports. T...
FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis
Basel, August 20, 2020 — Novartis today announced that the US Food and Drug Administration (FDA) has approved Kesimpta® (ofatumumab, formerly OMB157) as an injection for subcutaneous use for the trea...